XXXX for treatment of refractory @entity428 secondary to @entity879 .

@entity1 @entity137 @entity2657 @entity428 @entity879 @entity1578 @entity3352 @entity1443
PURPOSE: Successful use of i.v. @entity3352 for urgent management of @entity428 ( @entity428 ) due to @entity879 is reported. SUMMARY: A 42-year-old @entity1 receiving intensive care for fulminant @entity1578 secondary to @entity1443 @entity137 developed @entity2657 and @entity428 refractory to standard pharmacotherapy and respiratory support measures. A computed tomography (CT) scan of the @entity1 's head was ordered as part of an evaluation for liver transplantation, but the @entity1 's severely elevated @entity428 precluded supine positioning for the CT study (throughout the hospital stay, the head of the @entity1 's bed was kept at a 30   angle to optimize cerebral venous outflow). With administration of @entity3352 10 mg by i.v. injection, the @entity428 decreased from 29 to 13 mm Hg and remained at goal after the @entity1 was placed in a fully supine position for a period long enough to permit the CT scan. @entity3352 was used a second time to facilitate CT imaging several days later. No adverse effects attributable to @entity3352 use were documented. Although the @entity1 underwent successful liver transplantation, her mental status and overall clinical status continued to deteriorate and she died on postoperative day 12. CONCLUSION: Despite the poor overall @entity1 outcome in this case, i.v. @entity3352 was successfully used to decrease @entity428 in order to facilitate CT imaging as part of a transplantation eligibility workup.
